Peter Fecci
@PeterFecci
Followers
920
Following
7
Media
4
Statuses
52
Professor of Neurosurgery, Duke University; Director, Duke Center for Brain and Spine Metastasis *Views are my own
Durham, NC
Joined April 2017
"Fostering collaborations with local healthcare providers and providing info through trusted and respected channels...can help bridge the gap in healthcare disparities and improve outcomes in underserved regions," expresses CRI Lloyd J. Old STAR Dr. Iliev:
cancerresearch.org
CRI scientists discuss challenges and possible solutions for increasing access to cancer care and information in rural or remote communities.
0
2
5
Metastatic cancer treatments advance, offer new hope to patients - ABC11 Raleigh-Durham
abc11.com
"There's a lot of reasons to be optimistic even in the face of a terminal diagnosis."
0
1
11
Rep. Foushee Introduces Resolution Designating June as Brain and Spine Metastasis Awareness Month - Valerie Foushee. This as a result of the hard work of our outstanding DCBSM team!
foushee.house.gov
The Official U.S. Congressional website of Congresswoman Valerie Foushee
0
2
17
Congratulations to my latest graduate student to graduate: Alexandra Hoyt Miggelbrink, MD, PhD
0
2
37
NCI SPORE meeting at the beautiful new TMC3 facility at MD Anderson
0
6
28
Monteris Medical Announces Extended Aetna® Coverage of its NeuroBlate® System Laser Interstitial Thermal Therapy for Brain Tumor Patients - Monteris
monteris.com
Policy update extends coverage to more than 39 million lives MINNETONKA, Minn., Nov. 8, 2023 — Monteris Medical, the leader in minimally invasive image-guided laser interstitial thermal therapy...
1
0
16
Intracranial tumors elicit systemic sympathetic hyperactivity that limits immunotherapeutic responses https://t.co/MxuOftA9dE
#bioRxiv
0
1
2
Ep. 64: "Brain Tumor Immunotherapy" Featuring Dr. Peter Fecci - The Immunology Podcast
immunologypodcast.com
Dr. Peter Fecci is a Professor of Neurosurgery at Duke University and the Director of the Duke Center for Brain and Spine Metastasis. His research focuses on brain tumor immunology and immunotherapy,...
1
0
9
📣 Next week's episode features Dr. @PeterFecci from @DukeNeurosurg! His research focuses on brain tumor immunology and #immunotherapy. 🧠 Check out his lab's recent @NatureCancer paper on targeting MHC-I-negative tumor cells: https://t.co/7JDPFUWUse
0
3
11
⭐️NEW ARTICLE @NatureCancer “CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis” by @EmilyCLerner @PeterFecci & Co. Don’t miss it👇 https://t.co/lNyLUguG6x
https://t.co/Tu1IZGqh5Y
2
24
99
A Duke study published today in @NatureCancer disrupts a long-held paradigm for tumor resistance to #Immunotherapy. @EmilyCLerner @PeterFecci @prtbtcatduke @DukeCancer @DukeMedSchool @dukeresearch @dukemedicine
https://t.co/Z2qJtOqI9W
0
22
45
Life changing, dogma-smashing, textbook-changing, and awesome paper by @EmilyCLerner and @PeterFecci and the rest of the wonderful Fecci lab @SelenaLorrey @DSWilkinsonPhD and others who contributed to this amazing story https://t.co/HfBHv4KUaC
nature.com
Nature Cancer - Fecci and colleagues show that tumor cells having lost MHC-I, a major mechanism of immune escape, are amenable to killing by CD8+ T cells through an MHC-I-independent, alternative...
2
11
65
Poster from @DukeMedSchool student, member of @PeterFecci's lab and all-round superstar @AdenMendoza_ : "Association of Patient Race/Ethnicity with LITT Referral Patterns at a Single Center." #AANS2023
@FLNSUS
0
6
33
Excellent talks by @PeterFecci, @strahleMD, and many others at the #AANS2023 Guide to Successful Research session yesterday. Such valuable information that isn’t always covered for medical students. Some key takeaways:
1
3
28
Outcomes in Patients with Intact and Resected #BrainMetastasis Treated with 5-Fraction Stereotactic Radiosurgery @PeterFecci @JohnHSampson @ScottFl58722881
pmc.ncbi.nlm.nih.gov
Hypofractionated stereotactic radiosurgery (HF-SRS) with or without surgical resection is potentially a preferred treatment for larger or symptomatic brain metastases (BMs). Herein, we report...
0
1
3
Efficacy of Laser Interstitial Thermal Therapy (LITT) for Biopsy-Proven Radiation Necrosis in Radiographically Recurrent Brain Metastases https://t.co/4Zbwuzb3Cc
0
1
2
Looking forward to Friday morning wisdom for young neurosurgeons from @PeterFecci at #AANS2023
1
2
24
0
3
15
Amazing session discussing pearls for being a productive Neurosurgeon-Scientist Grateful for the expertise from the panel including @PeterFecci @isaacyangmd @JohnHShinMD @strahleMD @JamesRutka @DanielSciubba @Ricardokomotar @stonemcguire @nitinagarwalmd @AElsamadicyMD #AANS2023
#Repost @theyanglab1 ・・・ Kicking off Day 2 with the Dos and Don’ts of Neurosurgery Research! @isaacyangmd @jtr56 @strahles @aladine24 @thejnspg @jhshin312 @nitinagarwalmd @uclaneurosurgery @northwellhealth @pittneurosurgery @massgeneral @clevelandc… https://t.co/zx8BTWewIZ
0
4
20
#Wasserman Wednesday . Phenomenal @uclaneurosurgery Grand Rounds with Dr. Peter Fecci from @dukeneurosurgery and Dr. Michael Ivan from @umbti @umiamimedicine, @ucsfneurosurgery #alumni! . . #UCLAHealth #neurosurgery
0
1
5